Microdosing Testosterone – Interview with a Real Patient – Clinical Case Study

A clinical case study features a 57 year old patient describing a testosterone journey after military retirement. Persistent fatigue, weight gain, and low motivation are described despite repeated reassurance from primary care. Sleep studies and CPAP therapy are mentioned as partial steps that still left symptoms unresolved. Total testosterone around three hundred is discussed as technically in range yet clinically inadequate for this patient. A decision is described to seek a private clinic after several years of stalled progress. Initial weekly dosing at two hundred milligrams is described as excessive and difficult to tolerate. Side effects such as acne and higher estradiol are linked to the larger single weekly injections. The conversation frames microdosing as finding the minimum effective dose that supports sustainable health.

Dose refinement is described as moving from once weekly injections to twice weekly, then three times weekly. The schedule of Monday, Wednesday, and Friday injections is described as stabilizing estradiol and resolving acne. Typical microdoses of fifty milligrams are discussed, with a planned reduction toward forty milligrams for fine tuning. HCG use is discussed at two hundred fifty international units twice weekly to support testicular function. Injection technique is demonstrated using a twenty seven gauge insulin syringe that draws and injects with one needle. Sterile habits are emphasized, including alcohol cleaning of vial tops and injection sites before dosing. Slow injection technique is described as reducing post injection pain and preventing unnecessary bleeding. Needle size comparison is used to argue that large syringes create avoidable discomfort for many patients.

Laboratory review highlights hemoglobin around sixteen and hematocrit under fifty, supporting a stable blood picture. Phlebotomy history is discussed, with earlier quarterly donations reduced to twice yearly after ferritin dropped. Metabolic markers are reviewed with praise for tight glucose control and normal kidney electrolytes. ALT elevation is discussed as possibly muscle related, while fatty liver disease is mentioned as a differential. Cardiovascular screening includes a coronary calcium score of zero alongside a discussion of LDL goals. Crestor use is described at ten milligrams every other day as a targeted cholesterol countermeasure. Preventive care is reinforced with PSA monitoring, annual rectal exams, and planned colonoscopy scheduling. Travel advice recommends keeping testosterone in its prescription box and carrying documentation for airport screening. Long term commitment is stated, with discontinuation mentioned only if serious illness such as prostate cancer appears.